Skip to main content
Equibles

CITIGROUP INC

Position in IFRX — InflaRx N.V.

CIK 831001 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,914
+$1,751 QoQ
Shares Held
1,301
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 62 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. IFRX ranks #341 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in IFRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,914 1,301
2026-03-31 $1,163 1,302
2025-12-31 $1,314 1,301
2025-09-30 $1,743 1,301
2025-06-30 $1,027 1,301
2025-03-31 $1,327 1,301
2024-12-31 $3,213 1,301
2024-09-30 $1,990 1,301
2024-06-30 $2,263 1,301
2024-03-31 $1,850,003 1,201,301
2023-12-31 $1,958,120 1,201,301
2023-09-30 $3,876 1,301
2023-06-30 $5,802 1,301
2023-03-31 $2,523 1,301
2022-12-31 $4,033 1,301
2022-09-30 $3,434 1,301
2022-06-30 $2,147 1,481
2022-03-31 $12,452 6,805